Literature DB >> 16108301

The global burden of chronic kidney disease and the way forward.

C O Alebiosu1, O E Ayodele.   

Abstract

BACKGROUND: Chronic kidney disease (CKD) is increasing worldwide at an annual growth rate of 8%. Regional differences exist in the epidemiology of the condition, and non-Whites are more affected.
METHODS: An English-language literature search using Medline (January 1984-October 2003) was done to assess research/review articles on burden and prevention of CKD. Particular attention was paid to epidemiology and prevention of chronic kidney diseases.
RESULTS: The prevalence of CKD is higher in developing countries than in the developed world. The most common causes of CKD in the developing countries are chronic glomerulonephritis and systemic hypertension, diabetic nephropathy being the most common cause in Europe, the United States, and Japan. Factors contributing to the regional differences in the etiology and prevalence of CKD are race and ethnicity, genetic predisposition, increasing prevalence of type 2 diabetes, mortality caused by other disease, obesity, and possibly cigarette smoking. The control of hypertension, dyslipidemia, proteinuria, obesity, avoidance of low birth weight, smoking, and preventing ingesting of heavy metals such as lead are intervention strategies that retard or prevent progression of renal diseases. The magnitude of the existing burden of illness caused by renal failure, the projections for increasing incidence of CKD, and the limitations of our existing treatments for renal insufficiency all point to the need for clinical and population-based interventions aimed at prevention of CKD.
CONCLUSIONS: A comprehensive health education campaign and screening of the general populace are needed in order to detect chronic kidney disease early. These measures will ensure appropriate and timely institution of proven measures to halt or reduce progression of CKD.

Entities:  

Mesh:

Year:  2005        PMID: 16108301

Source DB:  PubMed          Journal:  Ethn Dis        ISSN: 1049-510X            Impact factor:   1.847


  47 in total

1.  Nicaragua revisited: evidence of lower prevalence of chronic kidney disease in a high-altitude, coffee-growing village.

Authors:  Timothy S Laux; Philip J Bert; Gerardo M Barreto Ruiz; Marvin González; Mark Unruh; Aurora Aragon; Cecilia Torres Lacourt
Journal:  J Nephrol       Date:  2012 Jul-Aug       Impact factor: 3.902

2.  Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected].

Authors:  Mark Nuijten; Daniela P Roggeri; Alessandro Roggeri; Paolo Novelli; Thomas S Marshall
Journal:  Clin Drug Investig       Date:  2015-04       Impact factor: 2.859

3.  The message for World Kidney Day 2009: hypertension and kidney disease: a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 8.237

4.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Clin Exp Nephrol       Date:  2009-01-28       Impact factor: 2.801

5.  The message for World Kidney Day 2009: hypertension and kidney disease-a marriage that should be prevented.

Authors:  George L Bakris; Eberhard Ritz
Journal:  Pediatr Nephrol       Date:  2009-01-17       Impact factor: 3.714

6.  Malnutrition in pre-dialysis chronic kidney disease patients in a teaching hospital in Southern Nigeria.

Authors:  Adejumo Oluseyi; Okaka Enajite
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 7.  Addressing the global burden of chronic kidney disease through clinical and translational research.

Authors:  Akinlolu Ojo
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 8.  Urinary proteomics using capillary electrophoresis coupled to mass spectrometry for diagnosis and prognosis in kidney diseases.

Authors:  Pedro Magalhães; Harald Mischak; Petra Zürbig
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-11       Impact factor: 2.894

9.  The Use of Curcumin for the Treatment of Renal Disorders: A Systematic Review of Randomized Controlled Trials.

Authors:  Mohammad Bagherniya; Davood Soleimani; Mohammad Hossein Rouhani; Gholamreza Askari; Thozhukat Sathyapalan; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

10.  Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.

Authors:  Oluseyi A Adejumo; Enajite I Okaka; Chimezie G Okwuonu; Ikponmwosa O Iyawe; Oluwole O Odujoko
Journal:  Ghana Med J       Date:  2016-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.